171 related articles for article (PubMed ID: 37396096)
1. Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity.
Sengar M; Hopman WM; Mohyuddin GR; Goodman AM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
Ecancermedicalscience; 2023; 17():1558. PubMed ID: 37396096
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity.
Wells JC; Fundytus A; Sharma S; Hopman WM; Del Paggio JC; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
Curr Oncol; 2022 Apr; 29(4):2530-2538. PubMed ID: 35448181
[TBL] [Abstract][Full Text] [Related]
4. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
5. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
Wells JC; Sharma S; Del Paggio JC; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
JAMA Oncol; 2021 Mar; 7(3):379-385. PubMed ID: 33507236
[TBL] [Abstract][Full Text] [Related]
6. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Pasalic D; McGinnis GJ; Fuller CD; Grossberg AJ; Verma V; Mainwaring W; Miller AB; Lin TA; Jethanandani A; Espinoza AF; Diefenhardt M; Das P; Subbiah V; Subbiah IM; Jagsi R; Garden AS; Fokas E; Rödel C; Thomas CR; Minsky BD; Ludmir EB
Eur J Cancer; 2020 Sep; 136():176-185. PubMed ID: 32702645
[TBL] [Abstract][Full Text] [Related]
7. Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled Trials.
Dodkins J; Hopman WM; Wells JC; Lievens Y; Malik RA; Pramesh CS; Gyawali B; Hammad N; Mukherji D; Sullivan R; Parkes J; Booth CM; Aggarwal A
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):500-508. PubMed ID: 35151802
[TBL] [Abstract][Full Text] [Related]
8. Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation.
Fundytus A; Wells JC; Sharma S; Hopman WM; Del Paggio JC; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):28-35. PubMed ID: 34479769
[TBL] [Abstract][Full Text] [Related]
9. Second-line systemic therapy for metastatic colorectal cancer.
Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
12. Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis.
Saleem K; Franz J; Klem ML; Yabes JG; Boyiadzis M; Jones JR; Shaikh N; Lontos K
Lancet Haematol; 2022 Dec; 9(12):e906-e918. PubMed ID: 36354020
[TBL] [Abstract][Full Text] [Related]
13. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.
Zichi C; Paratore C; Gargiulo P; Mariniello A; Reale ML; Audisio M; Bungaro M; Caglio A; Gamba T; Perrone F; Di Maio M
Eur J Cancer; 2021 May; 149():49-60. PubMed ID: 33823362
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).
Goldkuhle M; Dimaki M; Gartlehner G; Monsef I; Dahm P; Glossmann JP; Engert A; von Tresckow B; Skoetz N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012556. PubMed ID: 30001476
[TBL] [Abstract][Full Text] [Related]
15. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
[TBL] [Abstract][Full Text] [Related]
16. Aerobic physical exercise for adult patients with haematological malignancies.
Knips L; Bergenthal N; Streckmann F; Monsef I; Elter T; Skoetz N
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009075. PubMed ID: 30702150
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the Randomized Clinical Trial in the Era of Precision Oncology.
Del Paggio JC; Berry JS; Hopman WM; Eisenhauer EA; Prasad V; Gyawali B; Booth CM
JAMA Oncol; 2021 May; 7(5):728-734. PubMed ID: 33764385
[TBL] [Abstract][Full Text] [Related]
18. Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.
Piechotta V; Jakob T; Langer P; Monsef I; Scheid C; Estcourt LJ; Ocheni S; Theurich S; Kuhr K; Scheckel B; Adams A; Skoetz N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31765002
[TBL] [Abstract][Full Text] [Related]
19. Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation.
Tanaka K; Kawano M; Iwasaki T; Matsuda S; Itonaga I; Tsumura H
Sci Rep; 2020 May; 10(1):8573. PubMed ID: 32444660
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
